Lincoln Pharmaceuticals

L24230GJ1995PLC024288 · ISIN — · 2 filings, FY 2022-23 to FY 2023-24 · standalone basis

Reclaimed at end of life

Tonnes as filed. Totals combine re-used, recycled and safely disposed, because filers place comparable activity in different columns.

reporting_boundary_changed. Reporting boundary changed across years: FY 2022-23 Standalone basis, FY 2023-24 Standalone. Year-on-year figures cover different entities.

CategoryFY 2022-23FY 2023-24
Plastics including packaging not filed0
E-waste not filed0
Hazardous waste not filed0
Other waste not filednot filed
Total reclaimed 00

NIC codes filed

Products and services accounting for 90 percent of turnover, latest filing.

CodeDescription as filedShare of turnover
210 Manufacturing and trading of pharmaceuticals products like medicines, injections and other related products 100.00%

Source filings

YearBasisTaxonomyTurnover as filed
FY 2022-23 Standalone basis 2023-06-30 5,10,30,87,767.07
FY 2023-24 Standalone 2024-04-30 5,80,54,96,272

Figures read from BRSR XBRL as filed. Nothing estimated or restated. How this works · Report an error